Mao Xingmei, Peng Sixue, Lu Yan, Song Linjiang
School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Cells. 2025 Jul 14;14(14):1073. doi: 10.3390/cells14141073.
Cancer represents a significant global health hazard marked by elevated morbidity and mortality rates. Furthermore, the majority of tumor therapies encounter challenges, including metastasis, recurrence, and drug resistance. Consequently, it is essential to identify a specific and efficient tumor treatment approach. In recent years, the ongoing investigation and comprehension of tumors have led to significant attention towards cancer stem cells (CSCs). CSCs can facilitate tumor progression via self-renewal, differentiation capabilities, and multidrug resistance. Their function as a fundamental contributor to tumor heterogeneity, drug resistance, recurrence, and metastasis has emerged as a significant focus in cancer therapy research. In recent years, microRNAs (miRNAs) have been identified as crucial post-transcriptional regulators in biological processes, including chemosensitivity, self-renewal, apoptosis, invasion, and metastasis of cancer stem cells (CSCs). This paper systematically reviews the molecular mechanisms through which miRNAs influence the characteristics of cancer stem cells by targeting essential genes (e.g., SOX2, , c-Met) and modulating signaling pathways, including Wnt/β-catenin, Notch, Hedgehog, and PI3K/Akt. Furthermore, we investigated the viability of miRNAs as non-invasive biomarkers for cancer diagnosis and prognosis evaluation, examined the similarities and attributes of pivotal miRNAs in modulating cancer stem cell functionality, and deliberated on therapeutic approaches stemming from miRNA regulation of cancer stem cell activity. We anticipate that this research will yield novel insights into targeted cancer therapy.
癌症是一种重大的全球健康危害,其发病率和死亡率居高不下。此外,大多数肿瘤治疗都面临挑战,包括转移、复发和耐药性。因此,确定一种特定且有效的肿瘤治疗方法至关重要。近年来,对肿瘤的不断研究和理解使得癌症干细胞(CSCs)受到了广泛关注。癌症干细胞可通过自我更新、分化能力和多药耐药性促进肿瘤进展。它们作为肿瘤异质性、耐药性、复发和转移的重要促成因素,已成为癌症治疗研究的一个重要焦点。近年来,微小RNA(miRNAs)已被确定为生物过程中关键的转录后调节因子,包括癌症干细胞(CSCs)的化学敏感性、自我更新、凋亡、侵袭和转移。本文系统综述了微小RNA通过靶向关键基因(如SOX2、c-Met)和调节信号通路(包括Wnt/β-连环蛋白、Notch、Hedgehog和PI3K/Akt)影响癌症干细胞特征的分子机制。此外,我们研究了微小RNA作为癌症诊断和预后评估的非侵入性生物标志物的可行性,探讨了关键微小RNA在调节癌症干细胞功能方面的异同,并思考了基于微小RNA对癌症干细胞活性调节的治疗方法。我们预计这项研究将为靶向癌症治疗带来新的见解。